Corrigendum to: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials
Rheumatology (Oxford)
.
2021 Nov 3;60(11):5485.
doi: 10.1093/rheumatology/keab566.
Authors
Mark C Genovese
1
,
Eduardo Mysler
2
,
Tetsuya Tomita
3
,
Kim A Papp
4
,
Carlo Salvarani
5
,
Sergio Schwartzman
6
,
Gaia Gallo
7
,
Himanshu Patel
7
,
Jeffrey R Lisse
7
,
Andris Kronbergs
7
,
Soyi Liu Leage
7
,
David H Adams
7
,
Wen Xu
7
,
Helena Marzo-Ortega
8
,
Mark G Lebwohl
9
Affiliations
1
Department of Medicine, Stanford University Medical Center, Palo Alto, CA, USA.
2
Organización Medica de Investigación, Buenos Aires, Argentina.
3
Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
4
Clinical Research and Probity Medical Research Inc., Waterloo, and the University of Toronto, Toronto, Canada.
5
Azienda USL-IRCCS di Reggio Emilia, Università di Modena e Reggio Emilia, Modena, Emilia-Romagna, Italy.
6
Department of Medicine, The Hospital for Special Surgery, New York, NY.
7
Eli Lilly and Company, Indianapolis, IN, USA.
8
NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust and LIRMM, University of Leeds, Leeds, UK.
9
Department of Dermatology, Mount Sinai Hospital, New York, NY, USA.
PMID:
34549772
PMCID:
PMC8566904
DOI:
10.1093/rheumatology/keab566
No abstract available
Publication types
Published Erratum